focus -WSS

focus

author：comprehensive 2025-09-30 00:34:00 - browse：549

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Beam Therapeutics to lay off 20% of its staff, re

WSS

AstraZeneca bets AAV gene therapy will still deliver the goods

How climate

Why health workers in Gaza are injured or die at high rates

STAT Summit: Michael J. Fox on progress in Parkinson's research

First Opinion Podcast: Long Covid needs a new approach

HHS leader on health, climate change and biopharma emissions

focus

focus

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Continuity nursing helped my family in our darkest PICU moments

How a symptom of dementia informs our understanding of creativity

Virginia high school admissions case could be legal follow

Complete sequence of Y chromosome published for first time

Supreme Court strikes down use of affirmative action

Lawmakers consider Medicare pay reforms for doctors

Supreme Court strikes down use of affirmative action

Psilocybin's anti

leisure time

Australia’s approach to dialysis celebrates life

Pharmacists can make shortage drugs, but at what cost?

Study finds new variant for Parkinson’s in African populations

How to make AI work for medicine

Researchers explore possible ties between long Covid, menopause

What do new weight loss drugs mean for bariatric surgery?

knowledge

hotspot

Wikipedia

focus